
Eric Olson
Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1673, 1623 |
| Total Applications | 1758 |
| Issued Applications | 971 |
| Pending Applications | 175 |
| Abandoned Applications | 632 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5380341
[patent_doc_number] => 20090192180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Alpha-7 Nicotinic Receptor Agonists and Statins In Combination'
[patent_app_type] => utility
[patent_app_number] => 12/186915
[patent_app_country] => US
[patent_app_date] => 2008-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4934
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192180.pdf
[firstpage_image] =>[orig_patent_app_number] => 12186915
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/186915 | Alpha-7 Nicotinic Receptor Agonists and Statins In Combination | Aug 5, 2008 | Abandoned |
Array
(
[id] => 8189323
[patent_doc_number] => 08183224
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Purine derivatives as adenosine A1 receptor agonists and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/221539
[patent_app_country] => US
[patent_app_date] => 2008-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 44515
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/183/08183224.pdf
[firstpage_image] =>[orig_patent_app_number] => 12221539
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/221539 | Purine derivatives as adenosine A1 receptor agonists and methods of use thereof | Aug 3, 2008 | Issued |
Array
(
[id] => 5521986
[patent_doc_number] => 20090029967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'ADENOSINE A2A RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXTRA-PYRAMIDAL SYNDROME AND OTHER MOVEMENT DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/181736
[patent_app_country] => US
[patent_app_date] => 2008-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10069
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20090029967.pdf
[firstpage_image] =>[orig_patent_app_number] => 12181736
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/181736 | ADENOSINE A2A RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXTRA-PYRAMIDAL SYNDROME AND OTHER MOVEMENT DISORDERS | Jul 28, 2008 | Abandoned |
Array
(
[id] => 6258479
[patent_doc_number] => 20100029926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'MOLECULAR MASS ENHANCEMENT OF BIOLOGICAL FEEDSTOCKS'
[patent_app_type] => utility
[patent_app_number] => 12/181921
[patent_app_country] => US
[patent_app_date] => 2008-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4847
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029926.pdf
[firstpage_image] =>[orig_patent_app_number] => 12181921
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/181921 | Molecular mass enhancement of biological feedstocks | Jul 28, 2008 | Issued |
Array
(
[id] => 4711692
[patent_doc_number] => 20080300218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'CROSSLINKABLE POLYSACCHARIDE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, CROSSLINKABLE POLYSACCHARIDE COMPOSITION, AND MEDICAL TREATMENT MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 12/178030
[patent_app_country] => US
[patent_app_date] => 2008-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18680
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20080300218.pdf
[firstpage_image] =>[orig_patent_app_number] => 12178030
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/178030 | CROSSLINKABLE POLYSACCHARIDE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, CROSSLINKABLE POLYSACCHARIDE COMPOSITION, AND MEDICAL TREATMENT MATERIAL | Jul 22, 2008 | Abandoned |
Array
(
[id] => 5453215
[patent_doc_number] => 20090069252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'C-GLYCOSIDE DERIVATIVES AND SALTS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/173614
[patent_app_country] => US
[patent_app_date] => 2008-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37506
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20090069252.pdf
[firstpage_image] =>[orig_patent_app_number] => 12173614
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/173614 | C-glycoside derivatives and salts thereof | Jul 14, 2008 | Issued |
Array
(
[id] => 6483523
[patent_doc_number] => 20100008954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'Alpha-galactosyl ceramide analogs and their use as immunotherapies'
[patent_app_type] => utility
[patent_app_number] => 12/218082
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 114
[patent_figures_cnt] => 114
[patent_no_of_words] => 25688
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20100008954.pdf
[firstpage_image] =>[orig_patent_app_number] => 12218082
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/218082 | Alpha-galactosyl ceramide analogs and their use as immunotherapies | Jul 10, 2008 | Issued |
Array
(
[id] => 4600169
[patent_doc_number] => 07977473
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-07-12
[patent_title] => 'Use of non-crystalline cellulose as a medicine tablet medium'
[patent_app_type] => utility
[patent_app_number] => 12/214661
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 11
[patent_no_of_words] => 9235
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/977/07977473.pdf
[firstpage_image] =>[orig_patent_app_number] => 12214661
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/214661 | Use of non-crystalline cellulose as a medicine tablet medium | Jun 19, 2008 | Issued |
Array
(
[id] => 4886380
[patent_doc_number] => 20080260712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability'
[patent_app_type] => utility
[patent_app_number] => 12/214597
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10162
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20080260712.pdf
[firstpage_image] =>[orig_patent_app_number] => 12214597
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/214597 | Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability | Jun 19, 2008 | Abandoned |
Array
(
[id] => 6446483
[patent_doc_number] => 20100279961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'PHARMACEUTICAL COMPOSITION HAVING A TRIHYDROXY-CHROMENONE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 12/665879
[patent_app_country] => US
[patent_app_date] => 2008-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2426
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20100279961.pdf
[firstpage_image] =>[orig_patent_app_number] => 12665879
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665879 | PHARMACEUTICAL COMPOSITION HAVING A TRIHYDROXY-CHROMENONE DERIVATIVE | Jun 16, 2008 | Abandoned |
Array
(
[id] => 8152568
[patent_doc_number] => 08168803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-01
[patent_title] => 'Methods of using [3.2.0] heterocyclic compounds and analogs thereof'
[patent_app_type] => utility
[patent_app_number] => 12/136688
[patent_app_country] => US
[patent_app_date] => 2008-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 52
[patent_no_of_words] => 36164
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/168/08168803.pdf
[firstpage_image] =>[orig_patent_app_number] => 12136688
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/136688 | Methods of using [3.2.0] heterocyclic compounds and analogs thereof | Jun 9, 2008 | Issued |
Array
(
[id] => 4823086
[patent_doc_number] => 20080227729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS AND OTHER DISEASES WITH IMMUNOEFFECTOR COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/130907
[patent_app_country] => US
[patent_app_date] => 2008-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9371
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227729.pdf
[firstpage_image] =>[orig_patent_app_number] => 12130907
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/130907 | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds | May 29, 2008 | Issued |
Array
(
[id] => 4494577
[patent_doc_number] => 07956181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-07
[patent_title] => 'Trehalose fatty acid ester composition'
[patent_app_type] => utility
[patent_app_number] => 12/128023
[patent_app_country] => US
[patent_app_date] => 2008-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26472
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/956/07956181.pdf
[firstpage_image] =>[orig_patent_app_number] => 12128023
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/128023 | Trehalose fatty acid ester composition | May 27, 2008 | Issued |
Array
(
[id] => 8245054
[patent_doc_number] => 08202983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-19
[patent_title] => 'Thiocarbon-protecting groups for RNA synthesis'
[patent_app_type] => utility
[patent_app_number] => 12/118655
[patent_app_country] => US
[patent_app_date] => 2008-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26913
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/202/08202983.pdf
[firstpage_image] =>[orig_patent_app_number] => 12118655
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/118655 | Thiocarbon-protecting groups for RNA synthesis | May 8, 2008 | Issued |
Array
(
[id] => 4470000
[patent_doc_number] => 07943596
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-17
[patent_title] => 'Medicinal composition for ophthal use containing acetylated hyaluronic acid'
[patent_app_type] => utility
[patent_app_number] => 12/151702
[patent_app_country] => US
[patent_app_date] => 2008-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3348
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943596.pdf
[firstpage_image] =>[orig_patent_app_number] => 12151702
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/151702 | Medicinal composition for ophthal use containing acetylated hyaluronic acid | May 7, 2008 | Issued |
Array
(
[id] => 4960575
[patent_doc_number] => 20080275000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/114872
[patent_app_country] => US
[patent_app_date] => 2008-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7391
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20080275000.pdf
[firstpage_image] =>[orig_patent_app_number] => 12114872
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/114872 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | May 4, 2008 | Abandoned |
Array
(
[id] => 4860396
[patent_doc_number] => 20080269246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'METHOD FOR TREATING PEDIATRIC BIPOLAR DISORDER'
[patent_app_type] => utility
[patent_app_number] => 12/110522
[patent_app_country] => US
[patent_app_date] => 2008-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8919
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269246.pdf
[firstpage_image] =>[orig_patent_app_number] => 12110522
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/110522 | METHOD FOR TREATING PEDIATRIC BIPOLAR DISORDER | Apr 27, 2008 | Abandoned |
Array
(
[id] => 7535377
[patent_doc_number] => 08049003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-01
[patent_title] => 'Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 12/108228
[patent_app_country] => US
[patent_app_date] => 2008-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18396
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/049/08049003.pdf
[firstpage_image] =>[orig_patent_app_number] => 12108228
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/108228 | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof | Apr 22, 2008 | Issued |
Array
(
[id] => 4676863
[patent_doc_number] => 20080214494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'METHOD OF DRUG DELIVERY BY CARBON NANOTUBE-CHITOSAN NANOCOMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 12/105884
[patent_app_country] => US
[patent_app_date] => 2008-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5454
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214494.pdf
[firstpage_image] =>[orig_patent_app_number] => 12105884
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/105884 | Method of drug delivery by carbon nanotube-chitosan nanocomplexes | Apr 17, 2008 | Issued |
Array
(
[id] => 4886442
[patent_doc_number] => 20080260774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Alpha-galactosyl ceramide analogs and their use as immunotherapies'
[patent_app_type] => utility
[patent_app_number] => 12/082751
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 70
[patent_figures_cnt] => 70
[patent_no_of_words] => 26099
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20080260774.pdf
[firstpage_image] =>[orig_patent_app_number] => 12082751
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/082751 | Alpha-galactosyl ceramide analogs and their use as immunotherapies | Apr 13, 2008 | Abandoned |